BioSpace News Archive

Business

CORRECTING and REPLACING Axcella Reports Positive Top-Line Data from AXA1665-002 and Second Quarter Financial Results

Top-line data from AXA1665-002 show dose dependent improvements in markers of cognitive function and amino acid metabolism; both AXA1665 doses safe and well tolerated for 12 Weeks; plan to initiate Phase 2 clinical trial under IND in 1H 2021

August 5, 2020
·
18 min read
Policy

Life Spine Announces FDA 510(k) Clearance for the PLATEAU®-A Ti Anterior Lumbar Spacer System

Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced that it has received clearance from the U.S. Food & Drug Administration to market the PLATEAU-A Ti Anterior Lumbar Spacer System.

August 5, 2020
·
1 min read
Genetown

Blue Cross Blue Shield of Massachusetts to Issue More Than $100 Million in Premium Relief to Insured Customers and Members

Blue Cross Blue Shield of Massachusetts announced that it will return $101 million in premium refunds and anticipated rebates to its customers and members as a result of lower than anticipated health care costs during the COVID-19 public health emergency.

August 5, 2020
·
4 min read
Business

Rite Aid Names Paul Gilbert General Counsel

Rite Aid has named Paul Gilbert as its General Counsel and Corporate Secretary. Since joining Rite Aid on an interim basis earlier this year, Gilbert has played a key role in the company’s efforts to evolve into a destination for whole being health.

August 5, 2020
·
2 min read
Business

GeneCentric Therapeutics and Erasmus University Medical Center Enter Bladder Cancer Research Collaboration

Research to focus on potential biomarkers of disease progression, immune and treatment response in the setting of Non-Muscle Invasive Bladder Cancer

August 5, 2020
·
4 min read
Algernon Announces Enrollment of First Patient in 2b/3 Human Study of Ifenprodil for Treatment of COVID-19

Algernon Pharmaceuticals Inc. a clinical stage pharmaceutical development company, is pleased to announce that it has enrolled its first patient in its multinational Phase 2b/3 human study of NP-120 for the treatment of COVID-19.

August 5, 2020
·
6 min read
BioMidwest

Texas Startup Industrial Genetics Launches Surface and Wastewater Testing for the COVID-19 Virus (SARS-CoV-2)

Central Texas-based biotechnology startup Industrial Genetics announces the launch of its proprietary genetic testing technology to identify the virus that causes COVID-19, on surfaces and in wastewater.

August 5, 2020
·
3 min read
BioMidwest

OPKO Health to Participate in BTIG Virtual Biotechnology Conference

OPKO Health, Inc. announced that management will participate in a fireside chat at the BTIG Virtual Biotechnology Conference on Monday, August 10, 2020 at 9:00 a.m. Eastern time.

August 5, 2020
·
1 min read
Drug Development

Prothena Announces Phase 2 PASADENA Study Results to be Presented at International Congress of Parkinson’s Disease and Movement Disorders

Prothena Corporation plc announced that results from Part 1 of the Phase 2 PASADENA study of prasinezumab in early Parkinson’s disease was selected as an oral Top Abstract presentation at the upcoming virtual International Congress of Parkinson’s Disease and Movement Disorders Society.

August 5, 2020
·
5 min read
Business

Collegium Reports Net Income of $8.1 Million in the Second Quarter of 2020

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company committed to being the leader in responsible pain management, reported its financial results for the second quarter ended June 30, 2020 and provided a corporate update.

August 5, 2020
·
11 min read